サマリー

世界経済の回復に伴い、人工臓器とバイオニクスの2021年の成長も前年から大きく変化することが予想されます。弊社（LP Information）の最新調査によると、人工臓器とバイオニクスの世界市場規模は2021年の8944.1百万米ドルから2022年には百万米ドルとなり、2021年から2022年の間に％変化します。人工臓器とバイオニクスの世界市場規模は、2028年には15000百万米ドルに達し、分析期間2022-2028年に7.7%のCAGRで成長する見込みです。
米国の人工臓器およびバイオニクス市場は、2021年に百万米ドルの価値があり、予測期間2022-2028年に約 %のCAGRで成長すると予想されます。中国は、世界の人工臓器およびバイオニクス市場の % 市場を構成し、2028 年までに百万米ドルに達します。ヨーロッパでは、ドイツが2028年までに100万ドルに達し、2022年から2028年の間に年平均成長率(%)で推移すると予測されています。APACでは、他の注目すべき市場（日本、韓国）の成長率は、今後6年間、それぞれ％と％と予測されています。
世界の主な人工臓器・バイオニクス企業は、Fresenius Medical Care、Cochlear、Abiomed、ABBOTTなどです。収益面では、世界の上位2社が2021年にほぼ％のシェアを占めています。
本レポートでは、人工臓器・バイオニクス市場の製品タイプ、用途、主要プレイヤー、主要地域、国別の包括的な概要、市場シェア、成長機会を紹介しています。
タイプ別区分：2.3項では2017年から2022年までの内訳データ、10.7項では2028年までの予測データを掲載しています。
人工腎臓
人工心臓、人工心肺補助装置
人工内耳
人工肺
人工肝臓
人工膵臓
義手・義足
その他
用途別セグメント：2017年から2022年までの内訳データは2.4節、2028年までの予測は10.8節に記載
商品化
臨床研究
また、本レポートでは、地域別に市場を分割しています。第4章、第5章、第6章、第7章、第8章における内訳データ。
米州
米国
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
本レポートでは、市場の競争環境とそれに対応する主要企業の詳細な分析も行っています。本レポートで取り上げている主要なプレイヤー第3章における内訳データ
フレゼニウス・メディカル・ケア
コクレア
アビオメッド
ABBOTT
バクスター
ビー・ブラウン
旭化成株式会社
ニプロ
メドエル
東レ・メディカル
ソノバ
メドトロニック
ゲティンゲ(マケ)
ウィリアム・デマント
リヴァノヴァ（ソリン）
テルモ
杭州ニュートロン
シンカルディア
コーウェーブ
リステント・メディカル
エバハート
オープンバイオニクス
OYMotionテクノロジーズ
メビウス・バイオニクス

ページTOPに戻る

目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artificial Organs and Bionics Market Size 2017-2028
2.1.2 Artificial Organs and Bionics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Artificial Organs and Bionics Segment by Type
2.2.1 Artificial Kidney
2.2.2 Artificial Heart & Ventricular Assist Device
2.2.3 Cochlear Implant
2.2.4 Artificial Lung
2.2.5 Artificial Liver
2.2.6 Artificial Pancreas
2.2.7 Bionic Hands & Prosthetics
2.2.8 Others
2.3 Artificial Organs and Bionics Market Size by Type
2.3.1 Artificial Organs and Bionics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Artificial Organs and Bionics Market Size Market Share by Type (2017-2022)
2.4 Artificial Organs and Bionics Segment by Application
2.4.1 Commercialize
2.4.2 Clinical Research
2.5 Artificial Organs and Bionics Market Size by Application
2.5.1 Artificial Organs and Bionics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Artificial Organs and Bionics Market Size Market Share by Application (2017-2022)
3 Artificial Organs and Bionics Market Size by Player
3.1 Artificial Organs and Bionics Market Size Market Share by Players
3.1.1 Global Artificial Organs and Bionics Revenue by Players (2020-2022)
3.1.2 Global Artificial Organs and Bionics Revenue Market Share by Players (2020-2022)
3.2 Global Artificial Organs and Bionics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Artificial Organs and Bionics by Regions
4.1 Artificial Organs and Bionics Market Size by Regions (2017-2022)
4.2 Americas Artificial Organs and Bionics Market Size Growth (2017-2022)
4.3 APAC Artificial Organs and Bionics Market Size Growth (2017-2022)
4.4 Europe Artificial Organs and Bionics Market Size Growth (2017-2022)
4.5 Middle East & Africa Artificial Organs and Bionics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Artificial Organs and Bionics Market Size by Country (2017-2022)
5.2 Americas Artificial Organs and Bionics Market Size by Type (2017-2022)
5.3 Americas Artificial Organs and Bionics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Organs and Bionics Market Size by Region (2017-2022)
6.2 APAC Artificial Organs and Bionics Market Size by Type (2017-2022)
6.3 APAC Artificial Organs and Bionics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Artificial Organs and Bionics by Country (2017-2022)
7.2 Europe Artificial Organs and Bionics Market Size by Type (2017-2022)
7.3 Europe Artificial Organs and Bionics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Artificial Organs and Bionics by Region (2017-2022)
8.2 Middle East & Africa Artificial Organs and Bionics Market Size by Type (2017-2022)
8.3 Middle East & Africa Artificial Organs and Bionics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Artificial Organs and Bionics Market Forecast
10.1 Global Artificial Organs and Bionics Forecast by Regions (2023-2028)
10.1.1 Global Artificial Organs and Bionics Forecast by Regions (2023-2028)
10.1.2 Americas Artificial Organs and Bionics Forecast
10.1.3 APAC Artificial Organs and Bionics Forecast
10.1.4 Europe Artificial Organs and Bionics Forecast
10.1.5 Middle East & Africa Artificial Organs and Bionics Forecast
10.2 Americas Artificial Organs and Bionics Forecast by Country (2023-2028)
10.2.1 United States Artificial Organs and Bionics Market Forecast
10.2.2 Canada Artificial Organs and Bionics Market Forecast
10.2.3 Mexico Artificial Organs and Bionics Market Forecast
10.2.4 Brazil Artificial Organs and Bionics Market Forecast
10.3 APAC Artificial Organs and Bionics Forecast by Region (2023-2028)
10.3.1 China Artificial Organs and Bionics Market Forecast
10.3.2 Japan Artificial Organs and Bionics Market Forecast
10.3.3 Korea Artificial Organs and Bionics Market Forecast
10.3.4 Southeast Asia Artificial Organs and Bionics Market Forecast
10.3.5 India Artificial Organs and Bionics Market Forecast
10.3.6 Australia Artificial Organs and Bionics Market Forecast
10.4 Europe Artificial Organs and Bionics Forecast by Country (2023-2028)
10.4.1 Germany Artificial Organs and Bionics Market Forecast
10.4.2 France Artificial Organs and Bionics Market Forecast
10.4.3 UK Artificial Organs and Bionics Market Forecast
10.4.4 Italy Artificial Organs and Bionics Market Forecast
10.4.5 Russia Artificial Organs and Bionics Market Forecast
10.5 Middle East & Africa Artificial Organs and Bionics Forecast by Region (2023-2028)
10.5.1 Egypt Artificial Organs and Bionics Market Forecast
10.5.2 South Africa Artificial Organs and Bionics Market Forecast
10.5.3 Israel Artificial Organs and Bionics Market Forecast
10.5.4 Turkey Artificial Organs and Bionics Market Forecast
10.5.5 GCC Countries Artificial Organs and Bionics Market Forecast
10.6 Global Artificial Organs and Bionics Forecast by Type (2023-2028)
10.7 Global Artificial Organs and Bionics Forecast by Application (2023-2028)

11 Key Players Analysis
11.1 Fresenius Medical Care
11.1.1 Fresenius Medical Care Company Information
11.1.2 Fresenius Medical Care Artificial Organs and Bionics Product Offered
11.1.3 Fresenius Medical Care Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Fresenius Medical Care Main Business Overview
11.1.5 Fresenius Medical Care Latest Developments
11.2 Cochlear
11.2.1 Cochlear Company Information
11.2.2 Cochlear Artificial Organs and Bionics Product Offered
11.2.3 Cochlear Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Cochlear Main Business Overview
11.2.5 Cochlear Latest Developments
11.3 Abiomed
11.3.1 Abiomed Company Information
11.3.2 Abiomed Artificial Organs and Bionics Product Offered
11.3.3 Abiomed Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Abiomed Main Business Overview
11.3.5 Abiomed Latest Developments
11.4 ABBOTT
11.4.1 ABBOTT Company Information
11.4.2 ABBOTT Artificial Organs and Bionics Product Offered
11.4.3 ABBOTT Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 ABBOTT Main Business Overview
11.4.5 ABBOTT Latest Developments
11.5 Baxter
11.5.1 Baxter Company Information
11.5.2 Baxter Artificial Organs and Bionics Product Offered
11.5.3 Baxter Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Baxter Main Business Overview
11.5.5 Baxter Latest Developments
11.6 B.Braun
11.6.1 B.Braun Company Information
11.6.2 B.Braun Artificial Organs and Bionics Product Offered
11.6.3 B.Braun Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 B.Braun Main Business Overview
11.6.5 B.Braun Latest Developments
11.7 Asahi Kasei Corporation
11.7.1 Asahi Kasei Corporation Company Information
11.7.2 Asahi Kasei Corporation Artificial Organs and Bionics Product Offered
11.7.3 Asahi Kasei Corporation Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Asahi Kasei Corporation Main Business Overview
11.7.5 Asahi Kasei Corporation Latest Developments
11.8 Nipro
11.8.1 Nipro Company Information
11.8.2 Nipro Artificial Organs and Bionics Product Offered
11.8.3 Nipro Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Nipro Main Business Overview
11.8.5 Nipro Latest Developments
11.9 MED-EL
11.9.1 MED-EL Company Information
11.9.2 MED-EL Artificial Organs and Bionics Product Offered
11.9.3 MED-EL Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 MED-EL Main Business Overview
11.9.5 MED-EL Latest Developments
11.10 Toray Medical
11.10.1 Toray Medical Company Information
11.10.2 Toray Medical Artificial Organs and Bionics Product Offered
11.10.3 Toray Medical Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Toray Medical Main Business Overview
11.10.5 Toray Medical Latest Developments
11.11 Sonova
11.11.1 Sonova Company Information
11.11.2 Sonova Artificial Organs and Bionics Product Offered
11.11.3 Sonova Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Sonova Main Business Overview
11.11.5 Sonova Latest Developments
11.12 Medtronic
11.12.1 Medtronic Company Information
11.12.2 Medtronic Artificial Organs and Bionics Product Offered
11.12.3 Medtronic Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Medtronic Main Business Overview
11.12.5 Medtronic Latest Developments
11.13 Getinge (Maquet)
11.13.1 Getinge (Maquet) Company Information
11.13.2 Getinge (Maquet) Artificial Organs and Bionics Product Offered
11.13.3 Getinge (Maquet) Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Getinge (Maquet) Main Business Overview
11.13.5 Getinge (Maquet) Latest Developments
11.14 William Demant
11.14.1 William Demant Company Information
11.14.2 William Demant Artificial Organs and Bionics Product Offered
11.14.3 William Demant Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 William Demant Main Business Overview
11.14.5 William Demant Latest Developments
11.15 LivaNova (Sorin)
11.15.1 LivaNova (Sorin) Company Information
11.15.2 LivaNova (Sorin) Artificial Organs and Bionics Product Offered
11.15.3 LivaNova (Sorin) Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 LivaNova (Sorin) Main Business Overview
11.15.5 LivaNova (Sorin) Latest Developments
11.16 Terumo
11.16.1 Terumo Company Information
11.16.2 Terumo Artificial Organs and Bionics Product Offered
11.16.3 Terumo Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Terumo Main Business Overview
11.16.5 Terumo Latest Developments
11.17 Hangzhou Nurotron
11.17.1 Hangzhou Nurotron Company Information
11.17.2 Hangzhou Nurotron Artificial Organs and Bionics Product Offered
11.17.3 Hangzhou Nurotron Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Hangzhou Nurotron Main Business Overview
11.17.5 Hangzhou Nurotron Latest Developments
11.18 Syncardia
11.18.1 Syncardia Company Information
11.18.2 Syncardia Artificial Organs and Bionics Product Offered
11.18.3 Syncardia Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Syncardia Main Business Overview
11.18.5 Syncardia Latest Developments
11.19 CorWave
11.19.1 CorWave Company Information
11.19.2 CorWave Artificial Organs and Bionics Product Offered
11.19.3 CorWave Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 CorWave Main Business Overview
11.19.5 CorWave Latest Developments
11.20 Listent Medical
11.20.1 Listent Medical Company Information
11.20.2 Listent Medical Artificial Organs and Bionics Product Offered
11.20.3 Listent Medical Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Listent Medical Main Business Overview
11.20.5 Listent Medical Latest Developments
11.21 Evaheart
11.21.1 Evaheart Company Information
11.21.2 Evaheart Artificial Organs and Bionics Product Offered
11.21.3 Evaheart Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Evaheart Main Business Overview
11.21.5 Evaheart Latest Developments
11.22 Open Bionics
11.22.1 Open Bionics Company Information
11.22.2 Open Bionics Artificial Organs and Bionics Product Offered
11.22.3 Open Bionics Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Open Bionics Main Business Overview
11.22.5 Open Bionics Latest Developments
11.23 OYMotion Technologies
11.23.1 OYMotion Technologies Company Information
11.23.2 OYMotion Technologies Artificial Organs and Bionics Product Offered
11.23.3 OYMotion Technologies Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2020-2022)
11.23.4 OYMotion Technologies Main Business Overview
11.23.5 OYMotion Technologies Latest Developments
11.24 Mobius Bionics
11.24.1 Mobius Bionics Company Information
11.24.2 Mobius Bionics Artificial Organs and Bionics Product Offered
11.24.3 Mobius Bionics Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2020-2022)
11.24.4 Mobius Bionics Main Business Overview
11.24.5 Mobius Bionics Latest Developments
12 Research Findings and Conclusion